OHR PHARMACEUTICAL INC's ticker is OHRP and the CUSIP is 67778H200. A total of 43 filers reported holding OHR PHARMACEUTICAL INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $11,000 | -56.0% | 135,564 | -2.6% | 0.00% | – |
| Q3 2018 | $25,000 | -7.4% | 139,164 | 0.0% | 0.00% | – |
| Q2 2018 | $27,000 | -12.9% | 139,164 | 0.0% | 0.00% | – |
| Q1 2018 | $31,000 | -88.0% | 139,164 | 0.0% | 0.00% | – |
| Q4 2017 | $258,000 | +545.0% | 139,164 | +152.7% | 0.00% | – |
| Q3 2017 | $40,000 | +14.3% | 55,064 | 0.0% | 0.00% | – |
| Q2 2017 | $35,000 | -23.9% | 55,064 | 0.0% | 0.00% | – |
| Q1 2017 | $46,000 | -31.3% | 55,064 | +24.1% | 0.00% | – |
| Q4 2016 | $67,000 | -43.2% | 44,360 | +6.3% | 0.00% | – |
| Q3 2016 | $118,000 | -24.4% | 41,713 | -26.7% | 0.00% | – |
| Q2 2016 | $156,000 | -14.3% | 56,869 | +0.3% | 0.00% | – |
| Q1 2016 | $182,000 | -42.4% | 56,713 | +10.3% | 0.00% | – |
| Q4 2015 | $316,000 | +143.1% | 51,436 | +9.4% | 0.00% | – |
| Q3 2015 | $130,000 | -75.7% | 47,036 | -77.9% | 0.00% | – |
| Q2 2015 | $535,000 | -10.4% | 213,161 | -9.3% | 0.00% | – |
| Q1 2015 | $597,000 | -66.4% | 235,026 | +10.4% | 0.00% | -100.0% |
| Q4 2014 | $1,776,000 | +12.4% | 212,894 | -2.3% | 0.00% | – |
| Q3 2014 | $1,580,000 | +194.2% | 217,816 | +285.8% | 0.00% | – |
| Q2 2014 | $537,000 | +28.2% | 56,457 | +83.5% | 0.00% | – |
| Q1 2014 | $419,000 | – | 30,764 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |